Socorro Méndez-Martínez

Socorro Méndez-Martínez

Auto-generated profile, based on publicly available information

Socorro Méndez-Martínez

Instituto Mexicano del Seguro Social

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
ALAurelio López-Colombo
Aurelio López-Colombo
DMDouglas Morgan
Douglas Morgan
DBDalia Bravo-González
Dalia Bravo-González
AMAlvaro Montiel-Jarquín
Alvaro Montiel-Jarquín
SMSocorro Méndez-Martínez
Socorro Méndez-Martínez
MSMax Schmulson
Max Schmulson
Aims.The frequency of functional gastrointestinal disorders (FGIDs) in the general population of Mexico is unknown.Methods.To determine the prevalence of FGIDs, associated depression, and health care utilization, a population-based sampling strategy was used to select 500 households in the State of Tlaxcala, in central Mexico. Household interviews were conducted by two trained physicians using the Rome II Modular Questionnaire, a health-care and medication used questionnaire and the CES-D depression scale.Results.The most common FGIDs were IBS: 16.0% (95% CI: 12.9–19.5); functional bloating: 10.8% (8.2–13.9); unspecified functional bowel disorder: 10.6% (8.0–13.6); and functional constipation (FC): 7.4% (5.3–10.1). Uninvestigated heartburn was common: 19.6% (16.2–23.4). All FGIDs were equally prevalent among both genders, except for IBS (P=0.001), IBS-C (P<0.001), IBS-A/M (P=0.049), and FC (P=0.039) which were more frequent in women. Subjects with FGIDs reported higher frequencies of medical visits: 34.6 versus 16.8%; use of medications: 40.7 versus 21.6%; (bothP<0.001); and reported depression: 26.7 versus 6.7%, (P<0.001).Conclusion.In this first population-based study of FGIDs in Mexico, heartburn, IBS, functional distension, and FC were common. Only IBS, IBS-C, IBS-A/M, and FC were more frequent in women. Finally, FGIDs in Mexico had an increased burden of health care utilization and depression.

1 October 2019 in Autoimmunity Reviews
Verified
Journal Article
Closed access
PMPamela Munguia-Realpozo
Pamela Munguia-Realpozo
CMClaudia Mendoza-Pinto
Claudia Mendoza-Pinto
CBCristina Sierra Benito
Cristina Sierra Benito
RERicardo O. Escarcega
Ricardo O. Escarcega
MGMario Garcia-Carrasco
Mario Garcia-Carrasco
RCRicard Cervera
Ricard Cervera

1 July 2015 in Autoimmunity Reviews
Verified
Journal Article
Closed access
MCMario García Carrasco
Mario García Carrasco
CMC. Mendoza-Pinto
C. Mendoza-Pinto
SDS. Macias Díaz
S. Macias Díaz
MVM. Vera-Recabarren
M. Vera-Recabarren
LLL. Vázquez de Lara
L. Vázquez de Lara
ARA. Ruiz-Arguelles
A. Ruiz-Arguelles

1 November 2015 in Autoimmunity Reviews
Verified
Journal Article
Closed access
MGM. Garcia-Carrasco
M. Garcia-Carrasco
CMC. Mendoza-Pinto
C. Mendoza-Pinto
SMS. Macias-Diaz
S. Macias-Diaz
FLF. Vazquez de Lara
F. Vazquez de Lara
IEI. Etchegaray-Morales
I. Etchegaray-Morales
RCRicard Cervera
Ricard Cervera

13 February 2023 in Autoimmunity Reviews
Verified
Journal Article
Closed access
PMPamela Munguía-Realpozo
Pamela Munguía-Realpozo
IEIvet Etchegaray-Morales
Ivet Etchegaray-Morales
CMClaudia Mendoza-Pinto
Claudia Mendoza-Pinto
SMSocorro Méndez-Martínez
Socorro Méndez-Martínez
ÁOÁngel David Osorio-Peña
Ángel David Osorio-Peña
MGMario García-Carrasco
Mario García-Carrasco

1 April 2023 in Endocrine, Metabolic & Immune Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
MCMario García Carrasco
Mario García Carrasco
CMClaudia Mendoza-Pinto
Claudia Mendoza-Pinto
PMPamela Munguía-Realpozo
Pamela Munguía-Realpozo
IEIvet Etchegaray-Morales
Ivet Etchegaray-Morales
SVSandra Karina Vélez-Pelcastre
Sandra Karina Vélez-Pelcastre
MEMarco Escamilla-Márquez
Marco Escamilla-Márquez
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by damage to multiple systems and a higher risk of cardiovascular disease. In addition, several studies have found that insulin resistance (IR) is more prevalent in SLE patients than controls, increasing the risk of prediabetes, type 2 diabetes mellitus (T2DM) and morbidity. The objective of this review was to summarize the most relevant evidence about the relationship among IR, T2DM and SLE, including the effects of pro-inflammatory states, acute-phase proteins, pro-inflammatory cytokines, and pharmacological SLE treatment. A better understanding of the mechanisms involved in these comorbidities will allow better treatment strategies.